期刊文献+

胃滞留-漂浮型给药系统研究进展 被引量:7

Developments in Gastric Retenting-floating Drug Delivery System
下载PDF
导出
摘要 胃滞留 漂浮型给药系统以其特有的缓控释优势而成为很有前途的剂型。综述各类胃滞留 漂浮型制剂的作用原理、所用辅料、制备方法、优缺点及其体内评价方法。 Gastric retenting-floating drug delivery system(GRFDDS)has been one of the promising drug delivery systems due to its advantage in controlled drug release. The gastric retenting-floating theories, materials applied, preparation methods, characteristics and techniques of in vivo evaluation of GRFDDS were reviewed.
出处 《药学进展》 CAS 2004年第5期217-222,共6页 Progress in Pharmaceutical Sciences
关键词 胃滞留-漂浮型给药系统 研究进展 辅料 制备方法 药物控释 Gastric retenting-floating drug delivery system,Controlled drug release,Gastric retention
  • 相关文献

参考文献21

  • 1Davis D W. Method of swallowing a pill[P]. US: 3418999,1968-12-31.
  • 2Laby R H. Device for administration to ruminants[P]. US:3844285, 1974-10-29.
  • 3Singh N, Kim H. Floating drug delivery systems:an approach to oral controll-ed drug delivery via gastric retention[J]. J Controlled Release 2000, 63:235-259.
  • 4Atyabi F, Sharma HL, Mohammad H.A.H, et al. Controlled drug release from coated floating ion exchange resin beads[J].J Control elease,1996, 42:25-28.
  • 5Streubel A, Siepmann J, Bodmeier R. Floating microparticles based on low density foam powder[J]. Int J Pharm, 2002,241:279-292.
  • 6Iannuccelli V, Coppi G, Bernabei M T, et al. Air compartment multiple-unit system for prolonged gastric residence.Part I. Formulation study[J]. Int J Pharm, 1998, 174:47-54.
  • 7Soppimath K S, Kulkarni A R, Aminabhavi T M. Developmentof hollow microspheresas floating controlled-release systems for cardiovascular drugs: preparationand release characteristics[J]. Drug Dev Ind Pharm, 2001,27(6):507-515.
  • 8Lee J H, Park T G, Choi H K. Development of oral drug delivery system using floating microspheres[J]. J Microencapsulation, 1999, 16(6):715-729.
  • 9Wong P S L, David E, Phyllis I. Prolonged release active agent dosage form ad-apted for gastric retention[P]. US:6120803, 2000-09-19.
  • 10Berner B, Louie-Helm J. Tablet shapes to enhance gastric retention of swella--ble controlled-release oral dosage forms[P]. US:6488962, 2003-12-03.

同被引文献82

引证文献7

二级引证文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部